Foreseen Biotechnology reposted this
Ipsen announces global licensing agreement with Foreseen Biotechnology, adding second pre-clinical ADC to its portfolio
Foreseen Biotechnology
Biotechnology Research
An emerging biotechnology company that pioneered a high throughput integrated translational proteomics platform.
About us
We are an emerging biotechnology company that pioneered a high throughput integrated translational proteomics platform powered by AI-based data analytical system to accelerate discovery of novel targets for therapeutics and diagnostics that are clinically relevant. We are building a pipeline of novel product candidates for the diagnosis and treatment of cancer, inflammatory/autoimmune diseases and neurological disorders. Foreseen Biotechnology is incubated by Nest.Bio Ventures.
- Website
-
www.foreseenbio.com
External link for Foreseen Biotechnology
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Type
- Privately Held
Updates
-
We are proud to announce global licensing agreement with Ipsen for antibody-drug conjugate with first-in-class potential. We look forward to continuing the collaboration with our partner Ipsen.
Ipsen announces global licensing agreement with Foreseen Biotechnology, adding second pre-clinical ADC to its portfolio. Learn more: https://lnkd.in/d-hbdhSA
-